FMS (Fresenius Medical Care AG) 1-Year Sharpe Ratio: -1.40 (As of Jul. 11, 2026)


FMS Fresenius Medical Care AG FMS
74 GF Score
Price $24.02
GF Value $24.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG 1-Year Sharpe Ratio?

Fresenius Medical Care AG FMS +0.46% 74 1-Year Sharpe Ratio is -1.40 as of Jul. 11, 2026. GuruFocus rates FMS with a GF Score™ of 74/100 and a GF Value™ of $24.13 (Fairly Valued). The stock has 4 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-11), Fresenius Medical Care AG's 1-Year Sharpe Ratio is -1.40.

Fresenius Medical Care AG  (NYSE:FMS) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Fresenius Medical Care AG 1-Year Sharpe Ratio Related Terms

FMS vs HCA, THC, DVA: 1-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's 1-Year Sharpe Ratio falls into.


FMS
74GF Score
Fresenius Medical Care AG FMS
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.40 mean?
Fresenius Medical Care AG (FMS) has a 1-Year Sharpe Ratio of -1.40 as of Jul. 11, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's 1-Year Sharpe Ratio too high?
Fresenius Medical Care AG's current 1-Year Sharpe Ratio is -1.40. Overall, Fresenius Medical Care AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's 1-Year Sharpe Ratio compare to HCA and THC?
Fresenius Medical Care AG's 1-Year Sharpe Ratio of -1.40 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current 1-Year Sharpe Ratio is -1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $24.13, compared to a current price of $24.02 — trading 0.5% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.40. Fresenius Medical Care AG's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current 1-Year Sharpe Ratio is -1.40 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMS) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $24.02 is trading 0.5% below its estimated GF Value™ of $24.13. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMS:

  • 1-Year Sharpe Ratio: -1.40
  • GF Value™: $24.13 vs. price of $24.02 (0.5% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
74GF Score

Get the complete analysis for FMS

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.02
Price
$24.13
GF Value